Status:
COMPLETED
Treatment Uptake Chatbot for Eating Disorders
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Eating Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Eating disorders (EDs) are serious mental illnesses associated with high morbidity and mortality, clinical impairment, and comorbid psychopathology. Although evidence-based treatments for EDs have bee...
Eligibility Criteria
Inclusion
- U.S. resident
- English-speaking
- Age 18 years or older
- Owns a personal smartphone
- Screens positive for a Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) clinical or subclinical eating disorder
- Not currently receiving treatment for an eating disorder
Exclusion
- Non-U.S. resident
- Younger than 18 years old
- Does not own a personal smartphone
- Does not screen positive for a DSM-5 clinical or subclinical eating disorder
- Screens positive for Avoidant Restrictive Food Intake Disorder
- Currently receiving treatment for an eating disorder
Key Trial Info
Start Date :
March 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2022
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT04806165
Start Date
March 9 2021
End Date
May 9 2022
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110